These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34331459)

  • 21. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
    Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
    Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh.
    Al-Emran HM; Hasan MS; Ahasan Setu MA; Rahman MS; Alam ARU; Sarkar SL; Islam MT; Islam MR; Rahman MM; Islam OK; Jahid IK; Hossain MA
    J Infect Public Health; 2022 Feb; 15(2):156-163. PubMed ID: 34952247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert review on global real-world vaccine effectiveness against SARS-CoV-2.
    Chuenkitmongkol S; Solante R; Burhan E; Chariyalertsak S; Chiu NC; Do-Van D; Husin M; Hwang KP; Kiertiburanakul S; Kulkarni PS; Lee PI; Lobo RC; Nghia CH; Ong-Lim A; Sivasampu S; Suah JL; Tok PSK; Thwaites G;
    Expert Rev Vaccines; 2022 Sep; 21(9):1255-1268. PubMed ID: 35748494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
    PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models.
    van Doremalen N; Purushotham JN; Schulz JE; Holbrook MG; Bushmaker T; Carmody A; Port JR; Yinda CK; Okumura A; Saturday G; Amanat F; Krammer F; Hanley PW; Smith BJ; Lovaglio J; Anzick SL; Barbian K; Martens C; Gilbert SC; Lambe T; Munster VJ
    Sci Transl Med; 2021 Aug; 13(607):. PubMed ID: 34315826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19.
    Cha HH; Lim SY; Kwon JS; Kim JY; Bae S; Jung J; Kim SH
    Korean J Intern Med; 2022 Mar; 37(2):455-459. PubMed ID: 35272444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens.
    Klemis V; Schmidt T; Schub D; Mihm J; Marx S; Abu-Omar A; Ziegler L; Hielscher F; Guckelmus C; Urschel R; Wagenpfeil S; Schneitler S; Becker SL; Gärtner BC; Sester U; Sester M
    Nat Commun; 2022 Aug; 13(1):4710. PubMed ID: 35953492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory and cytotoxic mediators in COVID-19 patients and in ChAdOx1 nCoV-19 (AZD1222) vaccine recipients.
    Familiar-Macedo D; Vieira Damasco P; Fiestas Solórzano VE; Carnevale Rodrigues J; Sampaio de Lemos ER; Barreto Dos Santos F; Agudo Mendonça Teixeira de Siqueira M; Leal de Azeredo E; de-Oliveira-Pinto LM
    Cytokine; 2023 Nov; 171():156350. PubMed ID: 37672863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).
    Koen AL; Izu A; Baillie V; Kwatra G; Cutland CL; Fairlie L; Padayachee SD; Dheda K; Barnabas SL; Bhorat QE; Briner C; Ahmed K; Bhikha S; Bhiman JN; du Plessis J; Esmail A; Horne E; Hwa SH; Oommen-Jose A; Lambe T; Laubscher M; Malahleha M; Benade G; McKenzie S; Oelofse S; Patel F; Pillay S; Rhead S; Rodel H; Taoushanis C; Tegally H; Thombrayil A; Villafana TL; Gilbert S; Pollard AJ; Madhi SA
    Vaccine; 2023 May; 41(23):3486-3492. PubMed ID: 37149443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity.
    Liao SH; Chang WJ; Hsu CY; Ming-Fang Yen A; Lin TY; Li-Sheng Chen S; Hsiu-Hsi Chen T
    Vaccine; 2022 Nov; 40(47):6864-6872. PubMed ID: 36270891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
    Jantarabenjakul W; Chantasrisawad N; Puthanakit T; Wacharapluesadee S; Hirankarn N; Ruenjaiman V; Paitoonpong L; Suwanpimolkul G; Torvorapanit P; Pradit R; Sophonphan J; Putcharoen O
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):269-277. PubMed ID: 34717527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants.
    Damasceno DHP; Amaral AA; Silva CA; Simões E Silva AC
    Curr Med Chem; 2022; 29(15):2673-2690. PubMed ID: 34473613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study.
    Sritipsukho P; Khawcharoenporn T; Siribumrungwong B; Damronglerd P; Suwantarat N; Satdhabudha A; Chaiyakulsil C; Sinlapamongkolkul P; Tangsathapornpong A; Bunjoungmanee P; Nanthapisal S; Tanprasertkul C; Sritipsukho N; Mingmalairak C; Apisarnthanarak A; Tantiyavarong P
    Emerg Microbes Infect; 2022 Dec; 11(1):585-592. PubMed ID: 35114893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.
    Moslemi M; Ardalan M; Haramshahi M; Mirzaei H; Sani SK; Dastgir R; Dastgir N
    BMC Infect Dis; 2022 Mar; 22(1):217. PubMed ID: 35241013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination.
    Spataro R; Fisco G; La Bella V
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35110289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.
    Pattni K; Hungerford D; Adams S; Buchan I; Cheyne CP; García-Fiñana M; Hall I; Hughes DM; Overton CE; Zhang X; Sharkey KJ
    BMC Infect Dis; 2022 Mar; 22(1):270. PubMed ID: 35307024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
    Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
    Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes simplex virus retinitis following ChAdOx1 nCoV- 19 (Covishield) vaccination for SARS CoV 2: A case report.
    Singh J; More A; Shetty SB; Chaskar P; Sen A
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1282-1285. PubMed ID: 35587646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the impact of a single dose of ChAdOx1 nCoV-19 (recombinant) coronavirus vaccine on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre.
    Desai A; Desai P; Mehta J; Sachora W; Bharti N; Patel T; Sukhwani K; Jain A; Sorathiya D; Nanda V; Mehta P; Desai A
    Int J Infect Dis; 2021 Dec; 113():282-287. PubMed ID: 34688949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.
    Lambe T; Spencer AJ; Thomas KM; Gooch KE; Thomas S; White AD; Humphries HE; Wright D; Belij-Rammerstorfer S; Thakur N; Conceicao C; Watson R; Alden L; Allen L; Aram M; Bewley KR; Brunt E; Brown P; Cavell BE; Cobb R; Fotheringham SA; Gilbride C; Harris DJ; Ho CMK; Hunter L; Kennard CL; Leung S; Lucas V; Ngabo D; Ryan KA; Sharpe H; Sarfas C; Sibley L; Slack GS; Ulaszewska M; Wand N; Wiblin NR; Gleeson FV; Bailey D; Sharpe S; Charlton S; Salguero FJ; Carroll MW; Gilbert SC
    Commun Biol; 2021 Jul; 4(1):915. PubMed ID: 34312487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.